PTC Therapeutics, Inc. (PTCT) /
The debt of PTC Therapeutics, Inc. over the past 10 years
Chart PTC Therapeutics, Inc.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, PTC Therapeutics, Inc. had liquid cash of $1.95B and total debt of $286.63M: net cash of $1.66B. It had more liquid cash than debt at 9 of the 10 year-ends shown. Total debt was highest at the end of fiscal 2022 ($571.72M) and lowest at the end of fiscal 2016 ($98.22M).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.95B* | $286.63M | $1.66B |
| 2024ended Dec 31, 2024 | $1.14B* | $285.41M | $854.28M |
| 2023ended Dec 31, 2023 | $876.74M* | $284.21M | $592.53M |
| 2022ended Dec 31, 2022 | $410.7M* | $571.72M | -$161.02M |
| 2021ended Dec 31, 2021 | $773.38M* | $431.43M | $341.94M |
| 2020ended Dec 31, 2020 | $1.1B* | $309.14M | $794.5M |
| 2019ended Dec 31, 2019 | $686.56M* | $313.86M | $372.7M |
| 2018ended Dec 31, 2018 | $227.59M* | $153.01M | $74.57M |
| 2017ended Dec 31, 2017 | $191.25M* | $144.97M | $46.27M |
| 2016ended Dec 31, 2016 | $231.67M* | $98.22M | $133.45M |
Fiscal years as PTC Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on PTC Therapeutics, Inc.
- The revenue of PTC Therapeutics, Inc.
- The profitability of PTC Therapeutics, Inc.
- The cash flow of PTC Therapeutics, Inc.
- All of PTC Therapeutics, Inc.'s financials, charted
Companies of a similar size
- BROSDutch Bros Inc.
- ABCBAMERIS BANCORP
- MMSIMERIT MEDICAL SYSTEMS INC
- RDNTRadNet, Inc.
- GXOGXO Logistics, Inc.
Not investment advice. This page shows what PTC Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.